Enanta Pharmaceuticals Inc. buy BiotechBee
Start price
11.01.23
/
50%
€46.60
Target price
31.12.25
€60.00
Performance (%)
-30.47%
End price
05.05.23
€32.40
Summary
This prediction ended on 05.05.23 with a price of €32.40. The BUY prediction by BiotechBee for Enanta Pharmaceuticals Inc. performed very badly with a performance of -30.47%. BiotechBee has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Enanta Pharmaceuticals Inc. | -0.752% | -0.752% | -20.958% |
iShares Core DAX® | -1.180% | 0.780% | 12.701% |
iShares Nasdaq 100 | -2.823% | -2.419% | 28.746% |
iShares Nikkei 225® | -3.908% | 1.574% | 11.146% |
iShares S&P 500 | -1.012% | -0.335% | 27.036% |
According to BiotechBee what are the pros and cons of Enanta Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Enanta Pharmaceuticals Inc. diskutieren
Buy mit Kursziel 60,0
In the thread Trading Enanta Pharmaceuticals Inc.
Buy beendet